The U.S. Food and Drug Administration on Thursday approved Ionis Pharmaceuticals' drug to prevent instances of severe swelling in various parts of the body of patients with a rare genetic disorder.

Rhythm Pharmaceuticals (NASDAQ:RYTM) announced that U.S. and EU regulators have accepted for review a potential label ...

An herbal supplement that’s marketed as a cure-all for chronic pain and sold in gas stations and smoke shops is getting ...

Ionis Pharmaceuticals won FDA approval for a drug that prevents painful swelling attacks triggered by a rare genetic ...

The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New ...

The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' oral medication for a rare genetic disorder ...

A little boy in the Chicago area is battling a rare disease and desperately needs a drug treatment for a better life. The ...

U.S. health officials gave the Food and Drug Administration the power to quickly authorize veterinarians and farmers to treat ...

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...

The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...

The Food and Drug Administration (FDA) became authorized Tuesday to allow the use of animal drugs to treat or prevent ...